Jinhe Biotechnology: Feed additive red yeast rice has obtained product approval numberZhitong·Nov 3, 2025 at 01:51 AM002688+1.00%
Jinhe Biotechnology: Plans to sell assets for RMB 21.1212 millionZhitong·Oct 29, 2025 at 06:25 AM002688+1.00%
Jinhe Biotechnology plans to raise no more than 300 million yuan through a simplified procedure for private placementZhitong·Oct 14, 2025 at 04:49 AM002688+1.00%
Jinhe Biotechnology: Discloses a simplified procedure for issuing stocks in 2025Zhitong·Oct 14, 2025 at 04:02 AM002688+1.00%
Jinhe Biotechnology's controlling shareholder, Jinhe Holdings, has completed a reduction in holdings, totaling a 3% share reductionZhitong·Sep 4, 2025 at 06:36 AM002688+1.00%
Jinhe Biotechnology: Invests 10 million yuan to establish a wholly-owned subsidiary for petsZhitong·Aug 19, 2025 at 07:23 AM002688+1.00%
Jinhe Biotechnology established a new company, including cell technology research and development businessZhitong·Aug 18, 2025 at 02:24 AM002688+1.00%
Guohai Securities: The "Matthew Effect" in the animal protection industry intensifies, and pet pharmaceuticals and overseas expansion are expected to open up medium to long-term growth spaceZhitong·Aug 14, 2025 at 01:38 AM300119+1.73%688098+4.47%
Biological vaccine stocks strengthened, among which, Shen Lian Biomedical rose over 10%, Global Printing 10CM hit the daily limit, Guanhao Biotech and Sinovac Biotech rose over 7%, Saili Medical rose over 5%, Kanglao Weishi, Jinhe Biotechnology, and Vland Biotech rose over 4%, Yongshun Biotech, Dezhan Health, Junzheng Group, and Kanghua Biotech rose over 3%Zhitong·Jul 31, 2025 at 08:50 PM300238+3.14%603739+1.26%
The animal vaccine sector continues to rise, with Shen Lian Biomedical up over 10%Zhitong·Jul 31, 2025 at 08:38 PM002688+1.00%688098+4.47%
Jinhe Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 138 million yuan, an increase of 51.52%Zhitong·Jul 30, 2025 at 04:58 AM002688+1.00%
Jinhe Biotechnology plans to repurchase and cancel 2.1 million restricted stocks and notify creditors to declareZhitong·Jul 23, 2025 at 04:38 AM002688+1.00%
Jinhe Biotechnology: Net profit expected to increase by 40%-55% in the first half of the yearZhitong·Jul 13, 2025 at 03:26 AM002688+1.00%
Jinhe Biotechnology plans to invest 158 million yuan in the expansion and upgrading project of wastewater treatment capacity and water resource recyclingZhitong·Jul 7, 2025 at 07:12 AM002688+1.00%
Jinhe Biotechnology recently obtained a patent for the invention of a cat vaccine, and its layout in pet health protection is becoming increasingly completeZhitong·Jun 4, 2025 at 01:56 AM002688+1.00%
